Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sumei Liu has a total of 165 co-authors. Here are the top co-authors by number of shared publications:

  • Yun Xia

    Department of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, Ohio; Department of Anesthesiology, College of Medicine, The Ohio State University, Columbus, Ohio; and

    35 shared publications
  • Na Gao

    Department of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, Ohio 43210

    22 shared publications
  • Hong-Zhen Hu

    Departments of 1Physiology and Cell Biology, 2Pharmacology, 3Internal Medicine, 4Neuroscience, and 5Anesthesiolgy, The Ohio State University, College of Medicine, Columbus, Ohio

    20 shared publications
  • Jackie D. Wood

    Department of Physiology and Cell Biology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA

    18 shared publications
  • Jackie D. Wood

    Department of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, Ohio

    16 shared publications
  • Guo-Du Wang

    Department of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, Ohio

    15 shared publications

Latest Publications

  • Open Access

    Editorial: Advances in research on the role of inflammation in gut functional disorders

    by Li-Fei Zheng, Sumei Liu, Jin-Xia Zhu

    Editorial: Advances in research on the role of inflammation in gut functional disorders


  • Dopamine and Gastrointestinal Mucosa Function

    by Xiao-Yan Feng, Hong Xue, Zi-Hao Guo, Jing-Ting Yan, Sumei Liu, Jin-Xia Zhu


  • Dopamine Receptors in the Gastrointestinal Tract

    by Xiao-Li Zhang, Sumei Liu, Qi Sun, Jin-Xia Zhu


  • Effects of stress‐related peptides on chloride secretion in the mouse proximal colon

    by Sumei Liu, Aaron Karo, Sita Agterberg, Howard Hua, Aditi Bhargava

    Background: Stress increases intestinal secretion and exacerbates symptoms of irritable bowel syndrome (IBS). Peripherally derived corticotropin‐releasing factor (CRF) is known to mediate stress‐induced intestinal secretion, presumably by activation of CRF1 receptors in the gut. The present study aimed to ascertain the role of CRF2 activation in intestinal secretion by three other members of CRF peptide family, urocortin (UCN) 1–3, in wild type (WT) and CRF2 knockout (Crhr2−/−) mice.Methods: Mucosal/submucosal preparations from proximal colon of WT and Crhr2−/− mice of both sexes were mounted in Ussing chambers for measurement of short‐circuit current (Isc) as an indicator of ion secretion.Key Results: Male mice demonstrated a significantly higher baseline Isc than female in both WT and Crhr2−/− genotypes. CRF and UCN1‐3 (1 μM) caused greater increases in colonic Isc (ΔIsc) in male than female. Colonic Isc response to the selective CRF1 agonist, stressin1, was similar in both sexes. In male mice, the selective CRF2 agonists (UCN2 and UCN3) caused significantly greater ΔIsc than CRF and stressin1. UCN2‐ and UCN3‐evoked ΔISC was significantly reduced in preparations pretreated with the selective CRF2 antagonist antisauvagine‐30 and in Crhr2−/− mice. The prosecretory effects of urocortins were due to increases in Cl− secretion and involved enteric neurons and mast cells.Conclusions and Inference: The findings revealed sex differences in baseline colonic secretion and responses to stress‐related peptides. CRF2 receptors play a more prominent role in colonic secretion in male mice. The greater baseline secretion and responses to UCNs may contribute to the higher prevalence of diarrhea‐predominant IBS in males.


    • 25 June 2020
      • Vol. 72  (3) , 263-273

    Na+-K+-2Cl- symporter contributes to γ-aminobutyric acid-evoked excitation in rat enteric neurons.

    by Sumei Liu, Lifei Zheng, Kayla Neitzel, Tuo Ji, Wei Ren, Mei-Hua Qu

    Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter in the adult central nervous system (CNS), however, it causes excitation in the immature CNS neurons. The shift from GABA-induced depolarization to hyperpolarization in postnatal brain is primarily due to progressive decrease in the expression of the Na+-K+-2Cl- symporter 1 (NKCC1) and increased expression of the K+-Cl- cotransporter 2 (KCC2). Unlike CNS neurons, both immature and mature neurons in the enteric nervous system (ENS) are depolarized by GABA. Molecular mechanisms by which GABA excites ENS neurons are unclear. It is understood, however, that the excitatory action depends on elevated intraneuronal Cl-. We aimed to test a hypothesis that high intracellular Cl- in ENS neurons is maintained by activity of the NKCCs. We found that NKCC2 immunoreactivity (IR) was expressed in the ENS of the rat colon on postnatal day 1 (P1). The expression level of NKCC2 continuously increased and reached a steady high level on P14 and maintained at that level in adulthood. NKCC1 IR appeared in ENS on P14 and maintained through adulthood. KCC2 IR was not detectable in the ENS in any of the developmental stages. Both NKCC1 IR and NKCC2 IR were co-expressed with GABAA receptors in ENS neurons. Exogenous GABA (1 mmol/L) caused membrane depolarization in the ENS neurons. The reversal potential of GABA-induced depolarization was about -16 mV. Blockade of NKCC by bumetanide (50 μmol/L) or furosemide (300 μmol/L) suppressed the depolarizing responses to GABA. Bumetanide (50 μmol/L) shifted the reversal potential of GABA-induced depolarization in the hyperpolarizing direction. Neither the KCC blocker DIOA (20 μmol/L) nor the Cl-/HCO3- exchanger inhibitor DIDS (200 μmol/L) suppressed GABA-evoked depolarization. The results suggest that ENS neurons continuously express NKCC2 since P1 and NKCC1 since P14, which contribute to the accumulation of Cl- in ENS neurons and GABA-evoked depolarization in neonate and adult ENS neurons. These results provide the first direct evidence for the contribution of both NKCC2 and NKCC1 to the GABAA-mediated depolarization.


  • Neurotrophic factors in enteric physiology and pathophysiology

    by Sumei Liu

    Neurotrophic factors are traditionally recognized for their roles in differentiation, growth, and survival of specific neurons in the central and peripheral nervous system. Some neurotrophic factors are essential for the development and migration of the enteric nervous system along the fetal and post‐natal gut. Over the last two decades, several non‐developmental functions of neurotrophic factors have been characterized. In the adult gastrointestinal tract, neurotrophic factors regulate gut sensation, motility, epithelial barrier function, and protect enteric neurons and glial cells from damaging insults in the microenvironment of the gut. In this issue of Neurogastroenterology and Motility, Fu et al demonstrate that brain‐derived neurotrophic factor plays a role in the pathogenesis of distention‐induced abdominal pain in bowel obstruction. In light of this interesting finding, this mini‐review highlights some of the recent advances in understanding of the physiological and pathophysiological roles of neurotrophic factors in the adult gut.


  • Open Access

    Sleep and the gut microbiome: antibiotic-induced depletion of the gut microbiota reduces nocturnal sleep in mice

    by Jonathan Elliott Lendrum, Bradley Seebach, Barrett Klein, Sumei Liu

    Several bacterial cell wall components such as peptidoglycan and muramyl peptide are potent inducers of mammalian slow-wave sleep when exogenously administered to freely behaving animals. It has been proposed that the native gut microflora may serve as a quasi-endogenous pool of somnogenic bacterial cell wall products given their quantity and close proximity to the intestinal portal. This proposal suggests that deliberate manipulation of the host's intestinal flora may elicit changes in host sleep behavior. To test this possibility, we evaluated 24 h of sleep-wake behavior after depleting the gut microbiota with a 14 d broad-spectrum antibiotic regimen containing high doses of ampicillin, metronidazole, neomycin, and vancomycin. High-throughput sequencing of the bacterial 16S rDNA gene was used to confirm depletion of fecal bacteria and sleep-wake vigilance states were determined using videosomnography techniques based on previously established behavioral criteria shown to highly correlate with standard polysomnography-based methods. Additionally, considering that germ-free and antibiotic-treated mice have been earlier shown to display increased locomotor activity, and since locomotor activity has been used as a reliable proxy of sleep, we suspected that the elevated locomotor activity previously reported in these animals may reflect an unreported reduction in sleep behavior. To examine this potential relationship, we also quantified locomotor activity on a representative subsample of the same 24 h of video recordings using the automated video-tracking software ANY-maze. We found that antibiotic-induced depletion of the gut microbiota reduced nocturnal sleep, but not diurnal sleep. Likewise, antibiotic-treated mice showed increased nocturnal locomotor activity, but not diurnal locomotor activity. Taken together, these results support a link between the gut microbiome and nocturnal sleep and locomotor physiology in adult mice. Additionally, our findings indicate that antibiotics may be insomnogenic via their ability to diminish gut-derived bacterial somnogens. Given that antibiotics are among the most commonly prescribed drugs in human medicine, these findings have important implications for clinical practice with respect to prolonged antibiotic therapy, insomnia, and other idiopathic sleep-wake and circadian-rhythm disorders affecting an estimated 50-70 million people in the United States alone. Highlights: - 14 d broad-spectrum antibiotic treatment effectively depletes the gut microbiota. - Gut microbiota depletion reduces nocturnal sleep, but not diurnal sleep. - Gut microbiota depletion increases nocturnal locomotion, but not diurnal locomotion. - Antibiotics may be insomnogenic: implications for idiopathic sleep disorders.


  • Early‐life adversity, epigenetics, and visceral hypersensitivity

    by S. Liu, Si. Hagiwara, A. Bhargava

    Abdominal pain is associated with many gastrointestinal dysfunctions, such as irritable bowel syndrome (IBS), functional dyspepsia, and inflammatory bowel disease (IBD). Visceral hypersensitivity is a key reason for development of abdominal pain that presents in these gastrointestinal disorders/diseases. The pathogenesis of visceral hypersensitivity is complex and still far from being fully understood. In animal studies, visceral hypersensitivity has been linked to several early‐life adverse (ELA) events. In humans, IBD, functional dyspepsia, and IBS can have adult onset, though the adverse events that lead to visceral hypersensitivity are largely uncharacterized. In this issue of the journal, Aguirre et al. report the interesting finding that epigenetics underlies the effects of ELA events on visceral hypersensitivity. This mini‐review examines models of ELA events leading to visceral hypersensitivity and the potential role of epigenetics, as reported by Aguirre et al. and others.